Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.76 is 92% above its 5-year average of -9.29, near the high end of its 5-year range (-22.20–-0.76).
63.20% above its 12-month average of -2.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.13.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:55:36.940Z. Historical observations retain their original dates. Historical series through 2017-03-30.
EARNINGS PER SHARE (EPS)
-0.76
EARNINGS PER SHARE (EPS) AVG TTM
-2.06
EARNINGS PER SHARE (EPS) AVG 3Y
-5.59
EARNINGS PER SHARE (EPS) AVG 5Y
-9.29
EARNINGS PER SHARE (EPS) AVG 10Y
-29.61
EARNINGS PER SHARE (EPS) AVG 15Y
-3.24
EARNINGS PER SHARE (EPS) AVG 20Y
-10.20
CURRENT VS TTM AVG
+63.20%
CURRENT VS 3Y AVG
+86.41%
CURRENT VS 5Y AVG
+91.82%
CURRENT VS 10Y AVG
+97.43%
CURRENT VS 15Y AVG
+76.52%
CURRENT VS 20Y AVG
+92.55%
BioCardia, Inc.
Market Cap
$16.22M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$16.40M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$15.83M
Earnings Per Share (EPS)
-0.78
TTM Avg
-8.29
3Y Avg
-9461.74
5Y Avg
-302593.36
Market Cap
$16.64M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.73M
Earnings Per Share (EPS)
-4.76
TTM Avg
-17.55
3Y Avg
-9.83
5Y Avg
-7.78
Market Cap
$17.36M
Earnings Per Share (EPS)
-16.36
TTM Avg
46.76
3Y Avg
-158.09
5Y Avg
-209.03
Market Cap
$15.30M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
Market Cap
$17.01M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.99
3Y Avg
-1.87
5Y Avg
-3.18
Market Cap
$17.15M
Earnings Per Share (EPS)
-1.87
TTM Avg
-0.88
3Y Avg
-1.76
5Y Avg
-2.28
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $16.22M | -0.76 | -2.06 | -5.59 | -9.29 |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -0.21 | -0.22 | -0.25 | -0.30 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | -0.78 | -8.29 | -9461.74 | -302593.36 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -3.73 | -46.49 | -194.14 | -195.03 |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | -4.76 | -17.55 | -9.83 | -7.78 |
| PAVmed Inc. (PAVM)vs › | $17.36M | -16.36 | 46.76 | -158.09 | -209.03 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -0.77 | -1.25 | -1.82 | -1.86 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -0.48 | -0.99 | -1.87 | -3.18 |
| Lipocine Inc. (LPCN)vs › | $17.15M | -1.87 | -0.88 | -1.76 | -2.28 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.25M | -2.46 | -7.80 | -9.74 | -7.20 |
Trailing EPS (TTM)
$-0.76
Forward EPS (Est.)
$-0.63
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.23 |
| 2024-12-31 | -2.90 |
| 2023-12-31 | -8.19 |
| 2022-12-31 | -10.05 |
| 2021-12-31 | -11.19 |
| 2020-12-31 | -22.20 |
| 2019-12-31 | -39.15 |
| 2018-12-31 | -48.80 |
| 2017-12-31 | -43.50 |
| 2016-12-31 | -166.33 |
| 2015-12-31 | 27.86 |
| 2014-12-31 | 20.50 |
| 2013-12-31 | 0.13 |
| 2012-12-31 | 28.61 |
| 2011-12-31 | 64.80 |
| 2010-12-31 | -1079.54 |
| 2009-12-31 | -528.72 |
| 2008-12-31 | -742.35 |
| 2007-12-31 | -34.84 |
| 2007-06-30 | -8.21 |
| 2006-06-30 | -10.10 |
| 2005-06-30 | -98.42 |
| 2004-06-30 | -92.38 |
| 2003-06-30 | -61.30 |
| 2002-06-30 | -156.91 |
| 2001-06-30 | -275.16 |
| 2000-06-30 | -3293.43 |
| 1999-06-30 | -3087.89 |
| 1998-06-30 | -1459.85 |
| 1997-06-30 | -1463.41 |
